On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- New Jersey’s Department of Labor Adopts Regulations Implementing Key Sections of the Temporary Workers’ Bill of Rights
- In the Cloud: A Safe Place for Your Personal Data?
- Video: FTC Exits Labor Pact, EEOC Alleges Significant Underrepresentation in Tech, Sixth Circuit Affirms NLRB Ruling - Employment Law This Week
- Massachusetts High Court Rules That Franchisees Are Independent Contractors
- Video: New DOL Guidance - ERISA Plan Cybersecurity Update - Employment Law This Week